Chicago, 2018-04-14 - NBE-Therapeutics will attend the 2018 AACR conference in Chicago

NBE-Therapeutics' CEO Ulf Grawunder will be present at this year's AACR conference in Chicago, IL, in mid April

Read more

Berlin, 2018-03-27 - NBE-Therapeutics will present at 2018 World ADC congress

Ulf Grawunder, CEO of NBE-Therapeutics, to present at Hanson-Wade's 8th Annual World-ADC summit-Europe in Berlin at the end of March

Read more

Lisbon, Portugal, 2017-11-14 - NBE-Therapeutics presented update on R&D activities at 2017-PEGS conference

Roger R. Beerli, CSO of NBE-Therapeutics, will present an update on the company's ADC development activities

Read more

Basel, Switzerland, 2017-11-02 - NBE-Therapeutics presented update on R&D activities at 2017 HPAPI World Congress

Roger R. Beerli, CSO of NBE-Therapeutics, will present an update on the company's ADC development activities

Read more

Basel, 2017-11-01 - Ulf Grawunder invited for a presentation at the 2017 European Antibody Congress

Ulf Grawunder, CEO and founder of NBE-Therapeutics was invited to present an update on NBE-Therapeutics' ADC development activities at the 2017 European Antibody and World Immunotherapy Congress in Basel, Switzerland

Read more

next >